Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Raphael Heimgartner"'
Autor:
Sofie Brouwers, Raphael Heimgartner, Natallia Laptseva, Adriano Aguzzi, Niklas F. Ehl, Thomas Fehr, Felicitas Hitz, Hans H. Jung, Joel Kälin, Markus G. Manz, Beat Müllhaupt, Frank Ruschitzka, Harald Seeger, Georg Stussi, Markus Zweier, Andreas J. Flammer, Bernhard Gerber, Rahel Schwotzer
Publikováno v:
Swiss Medical Weekly, Vol 154, Iss 2 (2024)
AIMS OF THE STUDY: Systemic amyloidoses are rare protein-folding diseases with heterogeneous, often nonspecific clinical presentations. To better understand systemic amyloidoses and to apply state-of-the-art diagnostic pathways and treatment, the int
Externí odkaz:
https://doaj.org/article/cf69857cee974352a0bcd0080184335f
Autor:
Adalgisa Condoluci, Marie Théaudin, Rahel Schwotzer, Aju P. Pazhenkottil, Paolo Arosio, Manuela Averaimo, Ulrike Bacher, Peter Bode, Andrea Cavalli, Stefan Dirnhofer, Nadia Djerbi, Stephan Dobner, Thomas Fehr, Maura Garofalo, Ariana Gaspert, Sabine Gerull, Raphael Heimgartner, Annemarie Hübers, Hans H. Jung, Chiara Kessler, Raphael Knöpfel, Natallia Laptseva, Giulia Magini, Robert Manka, Luca Mazzucchelli, Martin Meyer, Violeta Mihaylova, Pierre Monney, Alessio Mylonas, René Nkoulou, Thomas Pabst, Otmar Pfister, Axel Rüfer, Adrian Schmidt, Harald Seeger, Simon F. Stämpfli, Guido Stirnimann, Thomas Suter, Giorgio Treglia, Alexandar Tzankov, Friederike Vetter, Markus Zweier, Andreas J. Flammer, Bernhard Gerber
Publikováno v:
Swiss Medical Weekly, Vol 151, Iss 4142 (2021)
This article was corrected and republished online on November 4, 2021. Please see Erratum (Swiss Med Wkly. 2021;151:w30104)
Externí odkaz:
https://doaj.org/article/a2cc0239496a4b7e934b23762969b699
Autor:
Rahel Schwotzer, Andreas J. Flammer, Sabine Gerull, Thomas Pabst, Paolo Arosio, Manuela Averaimo, Ulrike Bacher, Peter Bode, Andrea Cavalli, Adalgisa Condoluci, Stefan Dirnhofer, Nadia Djerbi, Stephan W. Dobner, Thomas Fehr, Maura Garofalo, Ariana Gaspert, Raphael Heimgartner, Annemarie Hübers, Hans H. Jung, Chiara Kessler, Raphael Knöpfel, Natallia Laptseva, Robert Manka, Luca Mazzucchelli, Martin Meyer, Violeta Mihaylova, Pierre Monney, Alessio Mylonas, René Nkoulou, Aju P. Pazhenkottil, Otmar Pfister, Axel Rüfer, Adrian Schmidt, Harald Seeger, Simon F. Stämpfli, Guido Stirnimann, Thomas Suter, Marie Théaudin, Giorgio Treglia, Alexandar Tzankov, Friederike Vetter, Markus Zweier, Bernhard Gerber
Publikováno v:
Swiss Medical Weekly, Vol 150, Iss 4950 (2020)
Systemic amyloidosis is a heterogeneous group of diseases associated with protein misfolding into insoluble beta-sheet rich structures that deposit extracellularly in different organs, eventually compromising their function. There are more than 30 di
Externí odkaz:
https://doaj.org/article/0e5c75901fcc4911aff0d76ae3910380
Autor:
Davide Rossi, Rahel Schwotzer, Raphael Heimgartner, Andreas J. Flammer, Georg Stussi, Bernhard Gerber, Guido Ghilardi, Erika Lerch, Christine Waibel, Harald Seeger, Clemens Caspar, Stefanie Pederiva, Thomas Fehr, Elena Bianchi, Markus G. Manz, Sofie Brouwers
Publikováno v:
Hematological Oncology. 37:595-600
Daratumumab, an anti-CD38 antibody, is effective in AL amyloidosis with low tumor burden. Data of daratumumab treatment in patients with AL amyloidosis but high tumor burden (≥10% bone marrow plasma cells) are limited. We report retrospective data
Autor:
Robert Manka, Alessio Mylonas, Andreas J. Flammer, Rene Nkoulou, Aju P. Pazhenkottil, Alexandar Tzankov, Natallia Laptseva, Andrea Cavalli, Violeta Mihaylova, Bernhard Gerber, Pierre Monney, Thomas Fehr, Friederike Vetter, Rahel Schwotzer, Stefan W Dobner, Manuela Averaimo, Raphael Heimgartner, Ariana Gaspert, Adrian Schmidt, Giorgio Treglia, Paolo Arosio, Stefan Dirnhofer, Luca Mazzucchelli, Thomas M. Suter, Chiara Kessler, Harald Seeger, Simon F. Stämpfli, Thomas Pabst, Vera Ulrike Bacher, Peter K. Bode, Axel Rüfer, Marie Théaudin, Guido Stirnimann, Adalgisa Concoluci, Annemarie Hübers, Markus Zweier, Sabine Gerull, Raphael Knöpfel, Nadia Djerbi, Martin Meyer, Maura Garofalo, Hans H. Jung, Otmar Pfister
Publikováno v:
Schwotzer, Rahel; Flammer, Andreas J; Gerull, Sabine; Pabst, Thomas; Arosio, Paolo; Averaimo, Manuela; Bacher, Vera; Bode, Peter; Cavalli, Andrea; Concoluci, Adalgisa; Dirnhofer, Stefan; Djerbi, Nadia; Dobner, Stephan W.; Fehr, Thomas; Garofalo, Maura; Gaspert, Ariana; Heimgartner, Raphael; Hübers, Annemarie; Jung, Hans H; Kessler, Chiara; ... (2020). Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosis. Swiss medical weekly, 150(w20364), w20364. EMH Media 10.4414/smw.2020.20364
Swiss Medical Weekly, 150
Swiss Medical Weekly, 150
Systemic amyloidosis is a heterogeneous group of diseases associated with protein misfolding into insoluble beta-sheet rich structures that deposit extracellularly in different organs, eventually compromising their function. There are more than 30 di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90fc639988820604965127bfa35f2680
Autor:
Erika Lerch, Guido Ghilardi, Georg Stussi, Thomas Fehr, Markus G. Manz, Elena Bianchi, Andreas J. Flammer, Sofie Brouwers, Bernhard Gerber, Rahel Schwotzer, Stefanie Pederiva, Christine Waibel, Davide Rossi, Harald Seeger, Raphael Heimgartner, Clemens Caspar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::847dbcda44611b6023cf8069b3ae95f1
https://doi.org/10.1002/hon.2677/v2/response1
https://doi.org/10.1002/hon.2677/v2/response1
Autor:
Natallia Laptseva, Martin Meyer, Adrian Schmidt, Guido Stirnimann, Annemarie Hübers, Alessio Mylonas, Andreas J. Flammer, Robert Manka, Manuela Averaimo, Andrea Cavalli, Hans H. Jung, Nadia Djerbi, Markus Zweier, Raphael Heimgartner, Ulrike Bacher, Ariana Gaspert, Otmar Pfister, Adalgisa Condoluci, Bernhard Gerber, Harald Seeger, Pierre Monney, Maura Garofalo, Aju P. Pazhenkottil, Friederike Vetter, Peter K. Bode, Sabine Gerull, Thomas M. Suter, Thomas Pabst, Rahel Schwotzer, Marie Théaudin, Raphael Knöpfel, Axel Rüfer, Giorgio Treglia, Stefan Dirnhofer, Luca Mazzucchelli, Chiara Kessler, Thomas Fehr, Giulia Magini, Rene Nkoulou, Alexandar Tzankov, Paolo Arosio, Simon F. Stämpfli, Violeta Mihaylova, Stephan Dobner
Publikováno v:
Swiss Medical Weekly. 151:w30053
Transthyretin amyloidosis (ATTR amyloidosis) is a disease caused by deposition of transthyretin fibrils in organs and tissues, which causes their dysfunction. The clinical heterogeneity of ATTR amyloidosis and the variable presentation of symptoms at